Abciximab: a reappraisal of its use in coronary care

Platelet reactivity plays a pivotal role in the pathogenesis of ischemic adverse events during and after acute coronary syndromes (ACS), and percutaneous coronary intervention (PCI). Glycoprotein (GP) IIb/IIIa inhibitors are the strongest antiplatelet agents currently available on the market and thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Valgimigli, Marco, Campo, Gianluca, Tebaldi, Matteo, Carletti, Roberto, Arcozzi, Chiara, Ferrari, Roberto, Percoco, Gianfranco
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727773/
https://www.ncbi.nlm.nih.gov/pubmed/19707425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727773/
https://www.ncbi.nlm.nih.gov/pubmed/19707425

Ejemplares similares